NCT05923060 2026-02-20
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
10 trialsNCT02662504 2026-02-05
MesoPDT
University Hospital, Lille
Phase 2 Completed
NCT03033225 2025-07-30
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
Mayo Clinic
Phase 2 Completed
NCT04140292 2022-06-24
Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT02628236 2017-09-18
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT00453336 2017-02-08
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
University of Miami
Phase 2 Completed
NCT02281136 2017-01-13
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT00217087 2015-12-24
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Mayo Clinic
Phase 2 Completed
NCT00083785 2007-04-11
Study of the Litxâ„¢ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
Light Sciences LLC
Phase 2 Completed
NCT00068068 2006-09-19
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
Light Sciences LLC
Phase 2 Completed